Reasons for adherence and nonadherence: A pilot study comparing first-and multi-episode schizophrenia patients

Clinical Schizophrenia and Related Psychoses

Volumn 7, Issue 4, 2014, Pages 199-206

  Sapra, Mamta ^a   Weiden, Peter J ^b   Schooler, Nina R ^c   Sunakawa McMillan, Ayako ^c   Uzenoff, Sarah ^d   Burkholder, Page ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d The University of North Carolina at Chapel Hill   (United States)

^e KINGS COUNTY HOSPITAL CENTER   (United States)

Author keywords

Adherence; Antipsychotics; First episode schizophrenia; Subjective reasons

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DENIAL; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; FAMILY; FEMALE; HUMAN; MALE; MEDICATION COMPLIANCE; MOTIVATION; PILOT STUDY; RELAPSE; SCHIZOPHRENIA; SELF REPORT;

ADHERENCE; ANTIPSYCHOTICS; FIRST-EPISODE SCHIZOPHRENIA; SUBJECTIVE REASONS;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; PILOT PROJECTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84892598786     PISSN: 19351232     EISSN: None     Source Type: Journal    
DOI: 10.3371/CSRP.SAWE.020813     Document Type: Article

References (31)

1. Malla A, Norman R, Schmitz N, Manchanda R, Bechard-Evans L, Takhar J, et al. Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study. Psychol Med 2006;36(5):649-658.
2. Malla A, Norman R, Bechard-Evans L, Schmitz N, Manchanda R, Cassidy C. Factors influencing relapse during a 2-year follow-up of first-episode psychosis in a specialized early intervention service. Psychol Med 2008;38(11):1585-1593.
3. Cassidy CM, Schmitz N, Norman R, Manchanda R, Malla A. Long-term effects of a community intervention for early identification of first-episode psychosis. Acta Psychiatr Scand 2008;117(6):440-448. (Pubitemid 351678476)
4. Weiden PJ, Buckley PF, Grody M. Understanding and treating first-episode schizophrenia. Psychiatr Clin North Am 2007;30(3):481-510.
5. Mojtabai R, Lavelle J, Gibson PJ, Sohler NL, Craig TJ, Carlson GA, et al. Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996. Psychiatr Serv 2002;53(3):337-339. (Pubitemid 34184688)
6. Mojtabai R, Lavelle J, Gibson PJ, Bromet EJ. Atypical antipsychotics in first admission schizophrenia: medication continuation and outcomes. Schizophr Bull 2003;29(3):519-530. (Pubitemid 37339386)
7. Miller BJ. A review of second-generation antipsychotic discontinuation in first-spisode psychosis. J Psychiatr Pract 2008;14(5):289-300.
8. Weiden PJ, Schooler NR, Weedon JC, Elmouchtari A, Sunakawa A, Goldfinger SM. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome. J Clin Psychiatry 2009;70(10):1397-1406.
9. Kamali M, Kelly BD, Clarke M, Browne S, Gervin M, Kinsella A, et al. A prospective evaluation of adherence to medication in first episode schizophrenia. Eur Psychiatry 2006;21(1):29-33. (Pubitemid 43243050)
10. Perkins DO, Johnson JL, Hamer RM, Zipursky RB, Keefe RS, Centorrhino F, et al.; HGDH Research Group. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res 2006;83(1):53-63.
11. Fennig S, Everett E, Bromet EJ, Jandorf L, Fennig SR, Tanenberg-Karant M, et al. Insight in first-admission psychotic patients. Schizophr Res 1996;22(3):257-263. (Pubitemid 27019293)
12. Gunderson JG, Frank AF, Katz HM, Vannicelli ML, Frosch JP, Knapp PH. Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. Schizophr Bull 1984;10(4):564-598.
13. Frank AF, Gunderson JG. The role of the therapeutic alliance in the treatment of schizophrenia. Arch Gen Psychiatry 1990;47(3):228-236.
14. Weiden P, Burkholder P, Schooler N, Weedon J, Uzenoff S, Turkington D. Improving antipsychotic adherence in schizophrenia: a randomized pilot study of a brief CBT intervention. Program and abstracts of the 160th Annual Meeting of the American Psychiatric Association; May 19-24, 2007; San Diego, California. Abstract NR803.
15. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13(2):261-276. (Pubitemid 18039085)
16. Addington D, Addington J, Patten S. Depression in people with first-episode schizophrenia. Br J Psychiatry Suppl 1998;172(33):90-92. (Pubitemid 28258905)
17. Guy W; National Institute of Mental Health (U.S.), Psychopharmacology Research Branch; Early Clinical Drug Evaluation Program. ECDEU assessment manual for psychopharmacology. Rockville (MD): U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976.
18. Weiden P, Rapkin B, Mott T, Zygmunt A, Goldman D, Horvitz-Lennon M, et al. Rating of medication influences (ROMI) scale in schizophrenia. Schizophr Bull 1994;20:297-310. (Pubitemid 24171093)
19. Novak-Grubic V, Tavcar R. Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder. Eur Psychiatry 2002;17(3):148-154. (Pubitemid 34800021)
20. Uzenoff SR, Perkins DO, Hamer RM, Wiesen CA, Penn DL. A preliminary trial of adherence-coping-education (ACE) therapy for early psychosis. J Nerv Ment Dis 2008;196(7):572-575.
21. Erickson DH, Beiser M, Iacono WG, Fleming JA, Lin TY. The role of social relationships in the course of first-episode schizophrenia and affective psychosis. Am J Psychiatry 1989;146(11):1456-1461. (Pubitemid 19271385)
22. Drake RJ, Dunn G, Tarrier N, Bentall RP, Haddock G, Lewis SW. Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. J Clin Psychiatry 2007;68(1):81-86. (Pubitemid 46220128)
23. Haddock G, Lewis S. Psychological interventions in early psychosis. Schizophr Bull 2005;31(3):697-704. (Pubitemid 41253319)
24. May PR, Van Putten T, Yale C, Potepan P, Jenden DJ, Fairchild MD, et al. Predicting individual responses to drug treatment in schizophrenia: a test dose model. J Nerv Ment Dis 1976;162(3):177-183.
25. Van Putten T, May PR. Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point. Arch Gen Psychiatry 1978;35(4):477-480. (Pubitemid 8337039)
26. May PR, Van Putten T, Yale C. Predicting outcome of antipsychotic drug treatment from early response. Am J Psychiatry 1980;137(9):1088-1089. (Pubitemid 10048887)
27. Kinon BJ, Ascher-Svanum H, Adams DH, Chen L. The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials. J Clin Psychopharmacol 2008;28(5):544-549.
28. Kinon BJ, Chen L, Ascher-Svanum H, Stauffer BL, Kollack-Walker S, Sniadecki JL, et al. Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia. Schizophr Res 2008;102(1-3):230-240.
29. McCabe R, Heath C, Burns T, Priebe S. Engagement of patients with psychosis in the consultation: conversation analytic study. BMJ 2002;325(7373):1148-1151. (Pubitemid 35398709)
30. Priebe S, McCabe R. The therapeutic relationship in psychiatric settings. Acta Psychiatr Scand Suppl 2006;(429):69-72. (Pubitemid 43340892)
31. Penn DL, Waldheter EJ, Perkins DO, Mueser KT, Lieberman JA. Psychosocial treatment for first-episode psychosis: a research update. Am J Psychiatry 2005;162(12):2220-2232. (Pubitemid 41740199)